Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-06-18 to 2025-06-20
Current total value of award: $58.9
Description: 4568673801!LORAZEPAM 2 MG/ML VIALML